Demystifying the R&D funding landscape
Watch this webinar by accessing the link at the bottom of this page. This is a recording of the live webinar held on 2 May 2012
This webinar will give an overview of the R&D funding landscape and will encompass the main schemes available to companies in the UK to help de-risk the technology innovation process. The talk will include opportunities for collaborative research and development as well as single company schemes such as Smart and SBRI. The role of Chemistry Innovation - a knowledge transfer network funded by the Technology Strategy Board - in supporting businesses to make the most of the opportunities available will also be highlighted.
Case studies will be presented to illustrate how certain schemes have been used in practice to help businesses grow and Plasticell - a pioneering biotechnology company founded in 2002 - will talk about their experience in using grant funding to progress their award-winning technology, Combinatorial Cell Culture (CombiCultT).
Dr Claire Claessen, Head of Projects, Chemistry Innovation Ltd
A physical chemist by training (BSc and PhD, University of Durham), Claire started her career with Unilever where she led global projects to bring new Homecare products to the market. Following this she spent two years in the Netherlands, as Marketing Manager for a food product company before returning to the UK to lead the development of a science strategy for the Northwest region (NWDA). Claire joined Chemistry Innovation in November 2011 as Head of Projects and oversees a portfolio of collaborative projects between industry and academia comprising >150 projects with an invested value in excess of £150million.
Yen Choo, Executive Chairman, Plasticell Ltd
Dr Choo is Executive Chairman of Plasticell Ltd and Chief Executive of Progenitor Labs Ltd. He is the founder of Plasticell and served as Chief Executive and Chief Scientist of the company.
Prior to his interest in stem cells he was a founder and Chief Scientist of Gendaq, a zinc finger engineering company acquired by Sangamo Biosciences, which developed the technology now marketed by Sigma-Aldrich. Previously he was a staff scientist at the MRC Laboratory of Molecular Biology, Cambridge, where he pioneered the engineering of protein-DNA interactions using combinatorial methods under Nobel laureate Sir Aaron Klug. Dr Choo holds a PhD in Molecular Biology from the University of Cambridge.
Moderator: David Rodham, Senior Consultant, Scientific Liason Advisory Services
Dr Rodham is an independent consultant, specialising in developing and managing collaborative R&D projects in the chemistry & life-science sector. Trained as a chemist, on leaving Oxford, Dr Rodham pursued PhD research in mammalian biophysics in Canada and post-doctoral work in The Royal Free Hospital and Imperial College.
He joined ICI corporate laboratories, supporting a variety of life-science business units and then moved to Zeneca Agrochemicals and Syngenta as a formulation specialist, before changing direction to manage a technology acquisition and collaborative R&D portfolio.
Supporting the scientific, technological and managerial application of chemical science across industry and commerce.
Join the Chemistry World webinar partnership programme; designed to connect you with your audience and to share topical information
Demistifying the R&D funding landscape
External links will open in a new browser window